Development of a novel PDL2-based immune therapy for cancer [ 2019 - ]

Research Grant

Researchers: Dr Michelle Wykes (Principal investigator) ,  A/Pr Victoria Atkinson ,  Prof Arlene Sharpe

Brief description Immuno-modulators utilise the patient’s own immune system to eliminate or slow the growth of cancer. Current therapies target a single molecule. This development grant would allow us to work towards developing novel treatment for cancer which targets two molecules at the same time.

Funding Amount $583,765.00

Funding Scheme Development Grants

Notes Development Grant